Kevan Herold

45PUBLICATIONS
127CO-AUTHORS
Solid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisGene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jun 04, 2026
A surviving beta cell subpopulation enriched in patients with T1D.

|Jan 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Carla J Greenbaum, S Alice Long, Stephen E Gitelman

|Nov 25, 2025
Towards insulin independence in type 1 diabetes: Prospects for prevention and cure.

Guy I Sydney, Ana Luisa Perdigoto, Kevan C Herold

|Nov 14, 2025
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.

Alfonso Galderisi, Alice L J Carr, Peter Taylor

|Nov 06, 2025
Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab.

Chantal Mathieu, Emily K Sims, Lucienne Chatenoud

|Jul 23, 2025
Humoral determinants of checkpoint immunotherapy.

Yile Dai, Lilach Aizenbud, Kai Qin

Pageof 8

Frequent Collaborators

14 joint publications

Carla J Greenbaum

9 joint publications

S Alice Long

7 joint publications

Michael J Haller

7 joint publications

Antoinette Moran